Robeco Institutional Asset Management B.V. Grows Stock Holdings in McKesson Corporation $MCK

Robeco Institutional Asset Management B.V. grew its holdings in shares of McKesson Corporation (NYSE:MCK) by 10.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 195,912 shares of the company’s stock after buying an additional 18,243 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.16% of McKesson worth $143,560,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of MCK. Brighton Jones LLC grew its stake in McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after buying an additional 798 shares during the period. Wellington Management Group LLP grew its stake in McKesson by 18.2% during the fourth quarter. Wellington Management Group LLP now owns 9,179 shares of the company’s stock worth $5,231,000 after buying an additional 1,413 shares during the period. Merit Financial Group LLC grew its stake in McKesson by 8.7% during the first quarter. Merit Financial Group LLC now owns 10,935 shares of the company’s stock worth $7,359,000 after buying an additional 875 shares during the period. Sentry Investment Management LLC purchased a new stake in McKesson during the first quarter worth approximately $287,000. Finally, Romano Brothers AND Company acquired a new position in shares of McKesson during the first quarter worth $226,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

McKesson Price Performance

MCK opened at $765.57 on Thursday. The stock has a market capitalization of $95.22 billion, a PE ratio of 30.52, a P/E/G ratio of 1.39 and a beta of 0.51. The firm’s fifty day moving average price is $701.10 and its 200 day moving average price is $701.71. McKesson Corporation has a 12-month low of $480.39 and a 12-month high of $776.14.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $8.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.33 by ($0.07). The company had revenue of $97.83 billion during the quarter, compared to analyst estimates of $95.93 billion. McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The company’s revenue was up 23.4% on a year-over-year basis. During the same period in the prior year, the company earned $7.88 earnings per share. On average, equities research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd were paid a dividend of $0.82 per share. The ex-dividend date was Tuesday, September 2nd. This is a positive change from McKesson’s previous quarterly dividend of $0.71. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s payout ratio is presently 13.08%.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 11,930 shares of the business’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $705.63, for a total transaction of $8,418,165.90. Following the completion of the sale, the chief executive officer owned 4,012 shares in the company, valued at $2,830,987.56. The trade was a 74.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the business’s stock in a transaction on Friday, August 8th. The shares were sold at an average price of $663.67, for a total transaction of $218,347.43. Following the sale, the chief accounting officer owned 657 shares of the company’s stock, valued at approximately $436,031.19. The trade was a 33.37% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 43,560 shares of company stock valued at $30,438,602. 0.08% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on MCK. TD Cowen boosted their target price on shares of McKesson from $830.00 to $864.00 and gave the stock a “buy” rating in a research report on Wednesday, September 24th. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a research report on Sunday. Cowen reissued a “buy” rating on shares of McKesson in a research report on Wednesday, September 24th. Leerink Partners boosted their target price on shares of McKesson from $785.00 to $850.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 24th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of McKesson from $775.00 to $856.00 and gave the stock a “buy” rating in a research report on Wednesday, September 24th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $829.08.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.